Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Open-market buy Director bought 21,940 shares at $5.49 ($120,451)
  2. 4 Open-market buy Chief Legal Officer bought 5,000 shares at $5.53 ($27,650)
  3. 4 Open-market buy President & CEO bought 30,000 shares at $5.55 ($166,500)
  4. 4 Open-market buy Chief Commercial Officer bought 30,000 shares at $5.47 ($164,100)
  5. 4 Shares withheld for taxes Chief R&D Officer gave up 7,525 shares (to pay taxes)
  6. 4 Grant or award Director acquired 999 shares (grant or award)
  7. 4 Grant or award Director acquired 999 shares (grant or award)
  8. 4 Gift President & CEO gave 20,000 shares (gift)
  9. 4 Shares withheld for taxes Chief R&D Officer gave up 5,580 shares (to pay taxes)
  10. 4 Shares withheld for taxes President & CEO gave up 14,089 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,482 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 2,482 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Legal Officer gave up 2,482 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief R&D Officer gave up 3,031 shares (to pay taxes)
  15. 4 Shares withheld for taxes President & CEO gave up 13,592 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Commercial Officer gave up 5,840 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 5,475 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Legal Officer gave up 4,015 shares (to pay taxes)
  19. 4 Grant or award Director acquired 956 shares (grant or award)
  20. 4 Grant or award Director acquired 956 shares (grant or award)

Page 6 of 49 · 965 filings